Collaboration will harness AI technology to address an aging-related target NOVATO, California, Aug. 14, 2018 /PRNewswire/ — The Buck Institute for Research on Aging, Insilico Medicine, Continue Reading
admin
Redefining Cause-Based Corporate Engagement
The Asia Pacific Leaders’ Malaria Alliance (APLMA) joins with Yoma Strategic and Shopee to end malaria SINGAPORE, Aug. 20, 2018 /PRNewswire/ — To mark World Continue Reading
Stealth BioTherapeutics Expands Pipeline, Advances New Compound
Stealth BioTherapeutics accelerates the development of a new pipeline candidate into Investigational New Drug enabling studies by leveraging Evotec’s INDiGO platform BOSTON, Aug. 15, 2018 Continue Reading
Mundipharma brings its cancer supportive care expertise to Vietnam after signing agreement with Helsinn Group for ALOXI(R) (palonosetron HCl)
– Mundipharma and Helsinn Group expand exclusive licensing and distribution agreement for anti-emetic medicine ALOXI® – This agreement builds on similar existing arrangements in a Continue Reading
Linkage, Inc. Awards Warren Bennis Leadership Award to Healthcare Leader Sir Andrew Witty
BURLINGTON, Massachusetts, Aug. 16, 2018 /PRNewswire/ — Linkage, Inc., a global leadership development consultancy, announced that it has awarded the 2018 Warren Bennis Award for Excellence Continue Reading
Ping An Good Doctor’s Revenue Rose by 150.3% Year-on-Year in the First Half of 2018
Actively Propel the Strategy of Globalization HONG KONG and SHANGHAI, Aug. 16, 2018 /PRNewswire/ — China’s leading one-stop healthcare ecosystem platform, Ping An Healthcare and Technology Company Continue Reading
Adlai Nortye Eyes Global Expansion With the Opening of Its First International Site in USA
BOSTON, Aug. 16, 2018 /PRNewswire/ — Adlai Nortye Ltd. (“Adlai Nortye” or “the Company”), a globally-focused biopharmaceutical company dedicated to becoming a leader in developing Continue Reading
Shanghai ChemPartner Announces Merger Deal Closure with Quantum
SHANGHAI, Aug. 17, 2018 /PRNewswire/ — Shanghai ChemPartner, a leading life science organization providing high-quality and cost-effective drug discovery and development services, announced the closure Continue Reading
Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology
– Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research – Expands company’s foundational CRISPR cutting and integration IP Continue Reading
Surescripts Recognized by Frost & Sullivan for Revolutionizing E-Prescribing with Prescription Price Transparency and Authorization at the Point of Care
SANTA CLARA, California, Aug. 15, 2018 /PRNewswire/ — Based on its recent analysis of the North America electronic prescribing market, Frost & Sullivan recognizes Surescripts Continue Reading